Role of DHEA in cardiovascular diseases

Biochemical Pharmacology

Volumn 85, Issue 6, 2013, Pages 718-726

  Savineau, Jean Pierre ^a,b   Marthan, Roger ^a,b,c   Dumas De La Roque, Eric ^b,c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CENTRE DE RECHERCHE CARDIO THORACIQUE DE BORDEAUX   (France)

^c HÔPITAL PELLEGRIN   (France)

Author keywords

Cardiovascular diseases; Dehydroepiandrosterone; Hypertension; Smooth muscle cell; Steroid hormones

Indexed keywords

CELL NUCLEUS RECEPTOR; CYCLIC GMP; CYTOSOL RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PRASTERONE; PROTEIN TYROSINE KINASE; RHO KINASE; SIGMA 1 OPIATE RECEPTOR; STAT3 PROTEIN; STEROID RECEPTOR; TRANSCRIPTION FACTOR NFAT;

ADRENAL CORTEX; AGE; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; DRUG MECHANISM; DRUG SYNTHESIS; ENDOTHELIAL DYSFUNCTION; HORMONE ACTION; HUMAN; IN VITRO STUDY; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; STEROID BLOOD LEVEL; STEROID METABOLISM; STEROIDOGENESIS;

EID: 84874118490     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.12.004     Document Type: Note

References (126)

1. W.L. Miller Androgen biosynthesis from cholesterol to DHEA Mol Cell Endocrinol 198 2002 7 14 (Pubitemid 36169929)
2. E.E. Baulieu, C. Corpechot, F. Dray, R. Emiliozzi, M.C. Lebeau, and P. Mauvais Jarvis An adrenal-secreted androgen: dehydroisoandrosterone sulfate. Its metabolism and a tentative generalization on the metabolism of other steroid conjugates in man Recent Prog Horm Res 21 1965 411 500
3. C.J. Migeon, A.R. Keller, B. Lawrence, and T.H. Shepard 2nd Dehydroepiandrosterone and androsterone levels in human plasma: effect of age and sex; day-to-day and diurnal variations J Clin Endocrinol Metab 17 1957 1051 1062
4. E.E. Baulieu Androgens and aging men Mol Cell Endocrinol 198 2002 41 49
5. A. Belanger, B. Candas, A. Dupont, L. Cusan, P. Diamond, and J.L. Gomez Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men J Clin Endocrinol Metab 79 1994 1086 1090 (Pubitemid 24342252)
6. F. Labrie, A. Belanger, L. Cusan, J.L. Gomez, and B. Candas Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging J Clin Endocrinol Metab 82 1997 2396 2402 (Pubitemid 27337846)
7. E.D. Schriock, C.K. Buffington, G.D. Hubert, B.R. Kurtz, A.E. Kitabchi, and J.E. Buster Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding J Clin Endocrinol Metab 66 1988 1329 1331
8. A.G. Schwartz, L. Pashko, and J.M. Whitcomb Inhibition of tumor development by dehydroepiandrosterone and related steroids Toxicol Pathol 14 1986 357 362 (Pubitemid 16000926)
9. P.R. Casson, R.N. Andersen, H.G. Herrod, F.B. Stentz, A.B. Straughn, and G.E. Abraham Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women Am J Obstet Gynecol 169 1993 1536 1539 (Pubitemid 24009191)
10. S. Aldred, and P. Mecocci Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients Arch Gerontol Geriatr 51 2010 e16 e18
11. A.J. Morales, J.J. Nolan, J.C. Nelson, and S.S. Yen Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age J Clin Endocrinol Metab 78 1994 1360 1367 (Pubitemid 24181005)
12. E. Barrett-Connor, and D. Goodman-Gruen The epidemiology of DHEAS and cardiovascular disease Ann N Y Acad Sci 774 1995 259 270 (Pubitemid 26140375)
13. E. Barrett-Connor, K.T. Khaw, and S.S. Yen A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease N Engl J Med 315 1986 1519 1524 (Pubitemid 17052150)
14. D.M. Herrington Dehydroepiandrosterone and coronary atherosclerosis Ann N Y Acad Sci 774 1995 271 280 (Pubitemid 26140376)
15. A.E. Hak, J.C. Witteman, F.H. de Jong, M.I. Geerlings, A. Hofman, and H.A. Pols Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study J Clin Endocrinol Metab 87 2002 3632 3639 (Pubitemid 34879505)
16. C.E. Bird, V. Masters, and A.F. Clark Dehydroepiandrosterone sulfate: kinetics of metabolism in normal young men and women Clin Invest Med 7 1984 119 122 (Pubitemid 14030894)
17. E. de Peretti, and M.G. Forest Pattern of plasma dehydroepiandrosterone sulfate levels in humans from birth to adulthood: evidence for testicular production J Clin Endocrinol Metab 47 1978 572 577 (Pubitemid 9010409)
18. T. Yamaji, M. Ishibashi, F. Takaku, A. Itabashi, S. Katayama, and J. Ishii Serum dehydroepiandrosterone sulfate concentrations in secondary adrenal insufficiency J Clin Endocrinol Metab 65 1987 448 451 (Pubitemid 17135165)
19. F. Labrie, V. Luu-The, A. Belanger, S.X. Lin, J. Simard, and G. Pelletier Is dehydroepiandrosterone a hormone J Endocrinol 187 2005 169 196
20. E.D. Lephart, C.R. Baxter, and C.R. Parker Jr. Effect of burn trauma on adrenal and testicular steroid hormone production J Clin Endocrinol Metab 64 1987 842 848 (Pubitemid 17044557)
21. R.S. Rosenfeld, B.J. Rosenberg, and L. Hellman Direct analysis of dehydroisoandrosterone in plasma Steroids 25 1975 799 805
22. E.E. Baulieu, G. Thomas, S. Legrain, N. Lahlou, M. Roger, and B. Debuire Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge study to a sociobiomedical issue Proc Natl Acad Sci U S A 97 2000 4279 4284 (Pubitemid 30226124)
23. L. Mazat, S. Lafont, C. Berr, B. Debuire, J.F. Tessier, and J.F. Dartigues Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality Proc Natl Acad Sci U S A 98 2001 8145 8150 (Pubitemid 32642701)
24. F. Labrie DHEA, important source of sex steroids in men and even more in women Prog Brain Res 182 2010 97 148
25. W.E. Rainey, B.R. Carr, H. Sasano, T. Suzuki, and J.I. Mason Dissecting human adrenal androgen production Trends Endocrinol Metab 13 2002 234 239 (Pubitemid 36733967)
26. F. Labrie, L. Cusan, J.L. Gomez, C. Martel, R. Berube, and P. Belanger Comparable amounts of sex steroids are made outside the gonads in men and women: strong lesson for hormone therapy of prostate and breast cancer J Steroid Biochem Mol Biol 113 2009 52 56
27. D. Liu, and J.S. Dillon Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3) J Biol Chem 277 2002 21379 21388 (Pubitemid 34952278)
28. D. Liu, and J.S. Dillon Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor Steroids 69 2004 279 289 (Pubitemid 38748724)
29. M. Chevalier, G. Gilbert, P. Lory, R. Marthan, J.F. Quignard, and J.P. Savineau Dehydroepiandrosterone; (DHEA) inhibits voltage-gated T-type calcium channels Biochem Pharmacol 83 2012 1530 1539
30. S. Bonnet, R. Paulin, G. Sutendra, P. Dromparis, M. Roy, and K.O. Watson Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-β/NFAT axis Circulation 120 2009 1231 1240
31. E.R. Levin Integration of the extranuclear and nuclear actions of estrogen Mol Endocrinol 19 2005 1951 1959 (Pubitemid 41124194)
32. B. Goodwin, M.R. Redinbo, and S.A. Kliewer Regulation of cyp3a gene transcription by the pregnane X receptor Annu Rev Pharmacol Toxicol 42 2002 1 23 (Pubitemid 34160517)
33. S.A. Kliewer, B. Goodwin, and T.M. Willson The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism Endocr Rev 23 2002 687 702 (Pubitemid 35191629)
34. L.B. Moore, D.J. Parks, S.A. Jones, R.K. Bledsoe, T.G. Consler, and J.B. Stimmel Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands J Biol Chem 275 2000 15122 15127 (Pubitemid 30337234)
35. S.L. Ripp, J.L. Fitzpatrick, J.M. Peters, and R.A. Prough Induction of CYP3A expression by dehydroepiandrosterone: involvement of the pregnane X receptor Drug Metab Dispos 30 2002 570 575 (Pubitemid 34456980)
36. K. Swales, and M. Negishi CAR, driving into the future Mol Endocrinol 18 2004 1589 1598 (Pubitemid 38864783)
37. K.P. Nephew, C.Q. Sheeler, M.D. Dudley, S. Gordon, S.G. Nayfield, and S.A. Khan Studies of dehydroepiandrosterone (DHEA) with the human estrogen receptor in yeast Mol Cell Endocrinol 143 1998 133 142 (Pubitemid 28458750)
38. M.R. Williams, T. Dawood, S. Ling, A. Dai, R. Lew, and K. Myles Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors J Clin Endocrinol Metab 89 2004 4708 4715 (Pubitemid 39244492)
39. M.R. Williams, S. Ling, T. Dawood, K. Hashimura, A. Dai, and H. Li Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs J Clin Endocrinol Metab 87 2002 176 181 (Pubitemid 34084688)
40. J. Sulcova, M. Hill, Z. Masek, R. Ceska, A. Novacek, and R. Hampl Effects of transdermal application of 7-oxo-DHEA on the levels of steroid hormones, gonadotropins and lipids in healthy men Physiol Res 50 2001 9 18 (Pubitemid 32233674)
41. T. Maurice, C. Gregoire, and J. Espallergues Neuro(active)steroids actions at the neuromodulatory sigma1 (sigma1) receptor: biochemical and physiological evidences, consequences in neuroprotection Pharmacol Biochem Behav 84 2006 581 597 (Pubitemid 350061234)
42. S.Y. Tsai, T. Hayashi, T. Mori, and T.P. Su Sigma-1 receptor chaperones and diseases Cent Nerv Syst Agents Med Chem 9 2009 184 189
43. Z.X. Cheng, D.M. Lan, P.Y. Wu, Y.H. Zhu, Y. Dong, and L. Ma Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors Exp Neurol 210 2008 128 136 (Pubitemid 351258075)
44. M.S. Bhuiyan, H. Tagashira, and K. Fukunaga Dehydroepiandrosterone- mediated stimulation of sigma-1 receptor activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding Cardiovasc Ther 29 2011 219 230
45. S. Bhuiyan, and K. Fukunaga Stimulation of Sigma-1 receptor by dehydroepiandrosterone ameliorates hypertension-induced kidney hypertrophy in ovariectomized rats Exp Biol Med (Maywood) 235 2010 356 364
46. H. Tagashira, S. Bhuiyan, N. Shioda, and K. Fukunaga Distinct cardioprotective effects of 17beta-estradiol and dehydroepiandrosterone on pressure overload-induced hypertrophy in ovariectomized female rats Menopause 18 2011 1317 1326
47. A. Abbasi, E.H. Duthie Jr., L. Sheldahl, C. Wilson, E. Sasse, and I. Rudman Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women J Am Geriatr Soc 46 1998 263 273 (Pubitemid 28117520)
48. N. Shono, S. Kumagai, Y. Higaki, M. Nishizumi, and H. Sasaki The relationships of testosterone, estradiol, dehydroepiandrosterone-sulfate and sex hormone-binding globulin to lipid and glucose metabolism in healthy men J Atheroscler Thromb 3 1996 45 51
49. P. Alexandersen, J. Haarbo, and C. Christiansen The relationship of natural androgens to coronary heart disease in males: a review Atherosclerosis 125 1996 1 13 (Pubitemid 26267117)
50. H.A. Feldman, C.B. Johannes, A.B. Araujo, B.A. Mohr, C. Longcope, and J.B. McKinlay Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study Am J Epidemiol 153 2001 79 89 (Pubitemid 32041900)
51. D.P. Trivedi, and K.T. Khaw Dehydroepiandrosterone sulfate and mortality in elderly men and women J Clin Endocrinol Metab 86 2001 4171 4177 (Pubitemid 32848531)
52. D.M. Herrington, G.B. Gordon, S.C. Achuff, J.F. Trejo, H.F. Weisman, and P.O. Kwiterovich Jr. Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography J Am Coll Cardiol 16 1990 862 870 (Pubitemid 20353406)
53. F. Ishihara, K. Hiramatsu, S. Shigematsu, T. Aizawa, A. Niwa, and N. Takasu Role of adrenal androgens in the development of arteriosclerosis as judged by pulse wave velocity and calcification of the aorta Cardiology 80 1992 332 338
54. L.E. Mitchell, D.L. Sprecher, I.B. Borecki, T. Rice, P.M. Laskarzewski, and D.C. Rao Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males Circulation 89 1994 89 93 (Pubitemid 24026476)
55. G.P. Bernini, A. Moretti, M. Sgro, G.F. Argenio, C.O. Barlascini, and R. Cristofani Influence of endogenous androgens on carotid wall in postmenopausal women Menopause 8 2001 43 50 (Pubitemid 32066579)
56. G.P. Bernini, M. Sgro, A. Moretti, G.F. Argenio, C.O. Barlascini, and R. Cristofani Endogenous androgens and carotid intimal-medial thickness in women J Clin Endocrinol Metab 84 1999 2008 2012 (Pubitemid 30647026)
57. M. Fukui, Y. Kitagawa, N. Nakamura, M. Kadono, M. Yoshida, and C. Hirata Serum dehydroepiandrosterone sulfate concentration and carotid atherosclerosis in men with type 2 diabetes Atherosclerosis 181 2005 339 344 (Pubitemid 41019615)
58. T. Suzuki, Y. Yano, M. Sakamoto, M. Uemura, T. Yasuma, and Y. Onishi Correlation of circulating dehydroepiandrosterone with activated protein C generation and carotid intima-media thickness in male patients with type 2 diabetes Diabet Med 29 2012 e41 e46
59. E. Barrett-Connor, and D. Goodman-Gruen Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study Circulation 91 1995 1757 1760
60. C. Berr, S. Lafont, B. Debuire, J.F. Dartigues, and E.E. Baulieu Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study Proc Natl Acad Sci U S A 93 1996 13410 13415 (Pubitemid 26382830)
61. S. Legrain, C. Berr, N. Frenoy, V. Gourlet, B. Debuire, and E.E. Baulieu Dehydroepiandrosterone sulfate in a long-term care aged population Gerontology 41 1995 343 351
62. R.S. Tilvis, M. Kahonen, and M. Harkonen Dehydroepiandrosterone sulfate, diseases and mortality in a general aged population Aging (Milano) 11 1999 30 34 (Pubitemid 29174098)
63. S.M. Haffner, S.E. Moss, B.E. Klein, and R. Klein Sex hormones and DHEA-SO4 in relation to ischemic heart disease mortality in diabetic subjects. The Wisconsin Epidemiologic Study of Diabetic Retinopathy Diabetes Care 19 1996 1045 1050 (Pubitemid 26334250)
64. S.H. Golden, A. Maguire, J. Ding, J.R. Crouse, J.A. Cauley, and H. Zacur Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort Am J Epidemiol 155 2002 437 445 (Pubitemid 34174155)
65. A. Hautanen, M. Manttari, V. Manninen, L. Tenkanen, J.K. Huttunen, and M.H. Frick Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study Atherosclerosis 105 1994 191 200 (Pubitemid 24086509)
66. A.Z. LaCroix, K. Yano, and D.M. Reed Dehydroepiandrosterone sulfate, incidence of myocardial infarction, and extent of atherosclerosis in men Circulation 86 1992 1529 1535
67. B. Zumoff, R.G. Troxler, J. O'Connor, R.S. Rosenfeld, J. Kream, and J. Levin Abnormal hormone levels in men with coronary artery disease Arteriosclerosis 2 1982 58 67 (Pubitemid 12111020)
68. J. Slowinska-Srzednicka, S. Zgliczynski, M. Ciswicka-Sznajderman, M. Srzednicki, P. Soszynski, and M. Biernacka Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction Atherosclerosis 79 1989 197 203 (Pubitemid 19226328)
69. J.H. Jansson, T.K. Nilsson, and Johnson O. von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction Heart 80 1998 334 337 (Pubitemid 28470762)
70. S. Kiechl, J. Willeit, E. Bonora, S. Schwarz, and Q. Xu No association between dehydroepiandrosterone sulfate and development of atherosclerosis in a prospective population study (Bruneck Study) Arterioscler Thromb Vasc Biol 20 2000 1094 1100 (Pubitemid 30207588)
71. K.T. Khaw, S. Tazuke, and E. Barrett-Connor Cigarette smoking and levels of adrenal androgens in postmenopausal women N Engl J Med 318 1988 1705 1709
72. S. Salvini, M.J. Stampfer, R.L. Barbieri, and C.H. Hennekens Effects of age, smoking and vitamins on plasma DHEAS levels: a cross-sectional study in men J Clin Endocrinol Metab 74 1992 139 143
73. F.C. Wu, and A. von Eckardstein Androgens and coronary artery disease Endocr Rev 24 2003 183 217 (Pubitemid 36515284)
74. A. Lasco, N. Frisina, N. Morabito, A. Gaudio, E. Morini, and A. Trifiletti Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women Eur J Endocrinol 145 2001 457 461 (Pubitemid 32927074)
75. H. Kawano, H. Yasue, A. Kitagawa, N. Hirai, T. Yoshida, and H. Soejima Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men J Clin Endocrinol Metab 88 2003 3190 3195 (Pubitemid 36877493)
76. D.M. Eich, J.E. Nestler, D.E. Johnson, G.H. Dworkin, D. Ko, and A.S. Wechsler Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation Circulation 87 1993 261 269 (Pubitemid 23019357)
77. G.B. Gordon, D.E. Bush, and H.F. Weisman Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury J Clin Invest 82 1988 712 720
78. M. Aragno, S. Parola, E. Brignardello, A. Mauro, E. Tamagno, and R. Manti Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats Diabetes 49 2000 1924 1931
79. S. Ayhan, C. Tugay, S. Norton, B. Araneo, and M. Siemionow Dehydroepiandrosterone protects the microcirculation of muscle flaps from ischemia-reperfusion injury by reducing the expression of adhesion molecules Plast Reconstr Surg 111 2003 2286 2294 (Pubitemid 36676807)
80. L. Nheu, L. Nazareth, G.Y. Xu, F.Y. Xiao, R.Z. Luo, and P. Komesaroff Physiological effects of androgens on human vascular endothelial and smooth muscle cells in culture Steroids 76 2011 1590 1596
81. T. Simoncini, P. Mannella, L. Fornari, G. Varone, A. Caruso, and A.R. Genazzani Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms Endocrinology 144 2003 3449 3455 (Pubitemid 36904421)
82. M. Akishita, M. Hashimoto, Y. Ohike, S. Ogawa, K. Iijima, and M. Eto Association of plasma dehydroepiandrosterone-sulfate levels with endothelial function in postmenopausal women with coronary risk factors Hypertens Res 31 2008 69 74 (Pubitemid 351325617)
83. D. Liu, H. Si, K.A. Reynolds, W. Zhen, Z. Jia, and J.S. Dillon Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression Endocrinology 148 2007 3068 3076 (Pubitemid 46996987)
84. S. Ling, A. Dai, M.R. Williams, K. Myles, R.J. Dilley, and P.A. Komesaroff Testosterone (T) enhances apoptosis-related damage in human vascular endothelial cells Endocrinology 143 2002 1119 1125 (Pubitemid 34164060)
85. G. Formoso, H. Chen, J.A. Kim, M. Montagnani, A. Consoli, and M.J. Quon Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1 via distinct phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-dependent pathways in vascular endothelium Mol Endocrinol 20 2006 1153 1163
86. S. Wu, Y. Ruan, M. Yin, and W. Lai Research on the age-related changes in the nitric oxide pathway in the arteries of rats and the intervention effect of dehydroepiandrosterone Gerontology 53 2007 234 237 (Pubitemid 46933385)
87. J.P. Camporez, E.H. Akamine, A.P. Davel, C.R. Franci, L.V. Rossoni, and C.R. Carvalho Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats J Physiol 589 2011 2585 2596
88. A.H. Goldfarb, M.K. McIntosh, and Boyer B.T. Vitamin E attenuates myocardial oxidative stress induced by DHEA in rested and exercised rats J Appl Physiol 80 1996 486 490 (Pubitemid 26061451)
89. R. Mastrocola, M. Aragno, S. Betteto, E. Brignardello, M.G. Catalano, and O. Danni Pro-oxidant effect of dehydroepiandrosterone in rats is mediated by PPAR activation Life Sci 73 2003 289 299 (Pubitemid 36579171)
90. M.H. Jacob, R. Janner Dda, A. Bello-Klein, S.F. Llesuy, and M.F. Ribeiro Dehydroepiandrosterone modulates antioxidant enzymes and Akt signaling in healthy Wistar rat hearts J Steroid Biochem Mol Biol 112 2008 138 144
91. C. Jia, X. Chen, X. Li, M. Li, C. Miao, and B. Sun The effect of DHEA treatment on the oxidative stress and myocardial fibrosis induced by Keshan disease pathogenic factors J Trace Elem Med Biol 25 2011 154 159
92. V. Gayosso, L.F. Montano, and R. Lopez-Marure DHEA-induced antiproliferative effect in MCF-7 cells is androgen- and estrogen receptor-independent Cancer J 12 2006 160 165
93. Y. Jiang, T. Miyazaki, A. Honda, T. Hirayama, S. Yoshida, and N. Tanaka Apoptosis and inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway in the anti-proliferative actions of dehydroepiandrosterone J Gastroenterol 40 2005 490 497 (Pubitemid 40823284)
94. G. Simonneau, I.M. Robbins, M. Beghetti, R.N. Channick, M. Delcroix, and C.P. Denton Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 2009 S43 S54
95. S. Bonnet, E. Dumas-de-La-Roque, H. Begueret, R. Marthan, M. Fayon, and P. Dos Santos Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension Proc Natl Acad Sci U S A 100 2003 9488 9493 (Pubitemid 37033955)
96. S. Bonnet, J.M. Hyvelin, P. Bonnet, R. Marthan, and J.P. Savineau Chronic hypoxia-induced spontaneous and rhythmic contractions in the rat main pulmonary artery Am J Physiol Lung Cell Mol Physiol 281 2001 L183 L192
97. B. Meyrick, and L. Reid Development of pulmonary arterial changes in rats fed Crotalaria spectabilis Am J Pathol 94 1979 37 50 (Pubitemid 9070535)
98. J.L. Lalich, W.D. Johnson, T.J. Raczniak, and R.C. Shumaker Fibrin thrombosis in monocrotaline pyrrole-induced cor pulmonale in rats Arch Pathol Lab Med 101 1977 69 73 (Pubitemid 8190019)
99. V. Hampl, J. Bibova, V. Povysilova, and J. Herget Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats Eur Respir J 21 2003 862 865 (Pubitemid 36592298)
100. M. Oka, V. Karoor, N. Homma, T. Nagaoka, E. Sakao, and S.M. Golembeski Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension Cardiovasc Res 74 2007 377 387 (Pubitemid 46693699)
101. E. Dumas de La Roque, N. Bellance, R. Rossignol, H. Begueret, M. Billaud, and P.D. Santos DHEA reverses chronic hypoxia/reoxygenation-induced right ventricular dysfunction in rats Eur Respir J 40 2012 1420 1429
102. E.H. Debonneuil, J. Quillard, and E.E. Baulieu Hypoxia and dehydroepiandrosterone in old age: a mouse survival study Respir Res 7 2006 144
103. N. Homma, T. Nagaoka, V. Karoor, M. Imamura, L. Taraseviciene-Stewart, and L.A. Walker Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone Am J Physiol Lung Cell Mol Physiol 295 2008 L71 L78
104. E. Dumas de La Roque, J.P. Savineau, A.C. Metivier, M.A. Billes, J.P. Kraemer, and S. Doutreleau Dehydroepiandrosterone (DHEA) improves pulmonary hypertension in chronic obstructive pulmonary disease (COPD): a pilot study Ann Endocrinol (Paris) 73 2012 20 25
105. S.L. Archer, D. Mike, J. Crow, W. Long, and E.K. Weir A placebo-controlled trial of prostacyclin in acute respiratory failure in COPD Chest 109 1996 750 755 (Pubitemid 26086944)
106. I. Blanco, E. Gimeno, P.A. Munoz, S. Pizarro, C. Gistau, and R. Rodriguez-Roisin Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension Am J Respir Crit Care Med 181 2010 270 278
107. D. Stolz, H. Rasch, A. Linka, M. Di Valentino, A. Meyer, and M. Brutsche A randomised, controlled trial of bosentan in severe COPD Eur Respir J 32 2008 619 628
108. N.W. Morrell, S. Adnot, S.L. Archer, J. Dupuis, P.L. Jones, and M.R. MacLean Cellular and molecular basis of pulmonary arterial hypertension J Am Coll Cardiol 54 2009 S20 S31
109. I.S. Farrukh, W. Peng, U. Orlinska, and J.R. Hoidal Effect of dehydroepiandrosterone on hypoxic pulmonary vasoconstriction: a Ca(2+)-activated K(+)-channel opener Am J Physiol 274 1998 L186 L195
110. + channels of hypoxic human pulmonary vascular cells Am J Respir Cell Mol Biol 20 1999 737 745 (Pubitemid 129495662)
111. + channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension Circulation 98 1998 1400 1406 (Pubitemid 28462800)
112. H.L. Reeve, E. Michelakis, D.P. Nelson, E.K. Weir, and S.L. Archer Alterations in a redox oxygen sensing mechanism in chronic hypoxia J Appl Physiol 90 2001 2249 2256 (Pubitemid 32467419)
113. S.A. Gupte, K.X. Li, T. Okada, K. Sato, and M. Oka Inhibitors of pentose phosphate pathway cause vasodilation: involvement of voltage-gated potassium channels J Pharmacol Exp Ther 301 2002 299 305 (Pubitemid 34250308)
114. S.Y. Lin, H. Cui, B. Yusta, and D.D. Belsham IGF-I signaling prevents dehydroepiandrosterone (DHEA)-induced apoptosis in hypothalamic neurons Mol Cell Endocrinol 214 2004 127 135 (Pubitemid 38210122)
115. M. Pap, and G.M. Cooper Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway J Biol Chem 273 1998 19929 19932 (Pubitemid 28377539)
116. H. Jiang, H. Li, and J.X. DiMario Control of slow myosin heavy chain 2 gene expression by glycogen synthase kinase activity in skeletal muscle fibers Cell Tissue Res 323 2006 489 494 (Pubitemid 43228104)
117. T. Shen, Z. Cseresnyes, Y. Liu, W.R. Randall, and M.F. Schneider Regulation of the nuclear export of the transcription factor NFATc1 by protein kinases after slow fibre type electrical stimulation of adult mouse skeletal muscle fibres J Physiol 579 2007 535 551 (Pubitemid 46351768)
118. R. Paulin, A. Courboulin, J. Meloche, V. Mainguy, E. Dumas de la Roque, and N. Saksouk Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension Circulation 123 2011 1205 1215
119. R. Paulin, J. Meloche, M.H. Jacob, M. Bisserier, A. Courboulin, and S. Bonnet Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension Am J Physiol Heart Circ Physiol 301 2011 H1798 H1809
120. J.R. Klinger The nitric oxide/cGMP signaling pathway in pulmonary hypertension Clin Chest Med 28 2007 143 167 ix (Pubitemid 46343758)
121. M.K. Steiner, I.R. Preston, J.R. Klinger, and N.S. Hill Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides Curr Opin Pharmacol 5 2005 245 250 (Pubitemid 40674246)
122. S. Bonnet, E.D. Michelakis, C.J. Porter, M.A. Andrade-Navarro, B. Thebaud, and S. Bonnet An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension Circulation 113 2006 2630 2641 (Pubitemid 43948012)
123. G.L. Semenza Involvement of hypoxia-inducible factor 1 in pulmonary pathophysiology Chest 128 2005 592S 594S (Pubitemid 43054145)
124. A. Dessouroux, Y. Akwa, and E.E. Baulieu DHEA decreases HIF-1alpha accumulation under hypoxia in human pulmonary artery cells: potential role in the treatment of pulmonary arterial hypertension J Steroid Biochem Mol Biol 109 2008 81 89
125. T. Nagaoka, Y. Morio, N. Casanova, N. Bauer, S. Gebb, and I. McMurtry Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats Am J Physiol Lung Cell Mol Physiol 287 2004 L665 L672
126. M. Oka, K.A. Fagan, P.L. Jones, and I.F. McMurtry Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension Br J Pharmacol 155 2008 444 454